News and Events

News and Events

Oncologist calls BioCurity's technology "Game Changing"

BioCurity has Received an Acceptance of Claims for the Company's Canadian Patent Application on the Reduction of Side Effects Caused by Radiation Therapy Combined with Chemotherapy. Notice of Allowance is Anticipated 3rd Quarter 2022

BioCurity Announces Notice of Allowance for the Company’s United States Patent Claims on Reduction of Side Effects Caused by Radiation Therapy Combined with Chemotherapy

Download Press Release March 29 2022

BioCurity Expanding Patent Portfolio Successes for Supportive Cancer Drugs Designed to Prevent Radiation Therapy Side Effects

Download Press Release March 10 2022

BioCurity Announces Presentation at ACRO Summit 2022 on Sensitizing Head and Neck Cancer to Radiation Using the Company’s Cerium Oxide Nanoparticles

Download Press Release March 10 2022

BioCurity Announces Presentation of Data on Cerium Oxide Nanoparticles to Sensitize Radiation for Head and Neck Cancer at ACRO 2022 Summit

Download Press Release January 12 2022

Follow Us

Stay in touch with us on social media and find out more about what we do.

Copyright © All Rights Reserved.

Share by: